NYSE · BRK-B
Berkshire Hathaway Inc.
$541.96+$1.62 (+0.3%)
Berkshire Hathaway Inc.’s quoted price sits in the upper half of its reported 52-week range, 1.45% below the high.
Loading market information…
NASDAQ · TDAC · USD
Stock price, earnings
Quote as of Oct 29, 2026, 08:00 PM UTC. Cached market data; not a live quote.
One-year closing-price history · USD. Historical prices are not a forecast.
Translational Development Acquisition Corp.’s quoted price sits in the upper half of its reported 52-week range, 0.91% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
BEHIND THE RESULTS
Upcoming dates and analyst estimates may change. Fiscal quarters follow Translational Development Acquisition Corp.’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Translational Development Acquisition Corp., founded in 2022 and headquartered in New York, New York, currently conducts no significant business operations. Its primary goal is to complete a business combination, such as a merger, amalgamation, share exchange, asset acquisition, share purchase, or reorganization, with one or more companies.
Latest available per-share figures in USD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 02:24 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
THE ANALYST VIEW
1 ratings in the current snapshot. Strong buy and strong sell are grouped with buy and sell.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
$541.96+$1.62 (+0.3%)
Berkshire Hathaway Inc.’s quoted price sits in the upper half of its reported 52-week range, 1.45% below the high.
$28.38$0.00 (0.0%)
Willow Lane Acquisition Corp.’s quoted price sits in the upper half of its reported 52-week range, 0.0% below the high.
$10.77+$0.01 (+0.09%)
FACT II Acquisition Corp’s quoted price sits in the upper half of its reported 52-week range, 0.09% below the high.
$10.52-$0.01 (-0.09%)
Sizzle Acquisition Corp. II’s quoted price sits in the upper half of its reported 52-week range, 0.19% below the high.
$10.80+$0.01 (+0.05%)
Cantor Equity Partners I, Inc. Class A Ordinary Shares’s quoted price sits in the upper half of its reported 52-week range, 1.55% below the high.
$10.85-$0.01 (-0.09%)
Newbury Street II Acquisition Corp’s quoted price sits in the lower half of its reported 52-week range, 10.63% below the high.
$7.73-$0.69 (-8.19%)
Melar Acquisition Corp. I’s quoted price sits in the lower half of its reported 52-week range, 53.15% below the high.
$10.33+$0.01 (+0.1%)
HCM III Acquisition Corp.’s quoted price sits in the upper half of its reported 52-week range, 0.0% below the high.
